Palvella Therapeutics, Inc. (PVLA) NASDAQ
122.44
-3.52(-2.79%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
122.44
-3.52(-2.79%)
Currency In USD
| Market Cap | 1.18B |
| Enterprise Value | 1.12B |
| P/E Ratio | -33.02 |
| PEG Ratio | -2.84 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 49.23 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -54.12 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.7 |
| Return On Equity | -0.98 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -35.9M |
| Net Income | -41.72M |
| Diluted EPS | -3.71 |
| Total Cash | 57.98M |
| Total Cash/Share | 5.15 |
| Total Debt | 633,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 5.2 |
| Book Value Per Share | 2.49 |
| 52-Week Change | 422.35 |
| 52-Week High | 151.18 |
| 52-Week Low | 20.2 |
| Moving Average 50 Days | 122.88 |
| Moving Average 200 Days | 84.87 |
| Average Volume | 314,640 |
| Shares Outstanding | 11.84M |
| % Held by Institutions | 88.21 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:80 |
| Last Split Date | April 23, 2024 |